Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Johnson and Johnson arm Janssen to discontinue Hepatitis C development programJohnson and Johnson arm Janssen to discontinue Hepatitis C development program
    US tribal patent deal could have big impact on generic drug marketUS tribal patent deal could have big impact on generic drug market
    Bristols drug cocktail cuts kidney cancer death risk 37 percentBristols drug cocktail cuts kidney cancer death risk 37 percent
    Lupin to add GLP 1 analog to its diabetes portfolio in IndiaLupin to add GLP 1 analog to its diabetes portfolio in India
    Glenmark gets USFDA approval for Rythmol SR genericGlenmark gets USFDA approval for Rythmol SR generic
    Panacea Biotec extends distribution pact with Canadian firm for USPanacea Biotec extends distribution pact with Canadian firm for US
    Teva to sell contraceptive brand Paragard in 1.1 billion dollar dealTeva to sell contraceptive brand Paragard in 1.1 billion dollar deal
    AbbVie says deaths in arthritis trial not linked to drugAbbVie says deaths in arthritis trial not linked to drug
    Regeneron, Sanofi asthma drug data fails to excite investorsRegeneron, Sanofi asthma drug data fails to excite investors
    Strides Shasun gets USFDA nod for kidney stone tabletsStrides Shasun gets USFDA nod for kidney stone tablets
    Sanofi launches Combiflam Icyhot pain relief topical in IndiaSanofi launches Combiflam Icyhot pain relief topical in India
    Novartis posts a win, Roche a flop in skin cancer trialsNovartis posts a win, Roche a flop in skin cancer trials
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system, invites comments

    CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system,...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok